A detailed history of American Century Companies Inc transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 38,785 shares of FDMT stock, worth $161,345. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,785
Previous 34,356 12.89%
Holding current value
$161,345
Previous $371,000 41.78%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$5.3 - $10.41 $23,473 - $46,105
4,429 Added 12.89%
38,785 $216,000
Q3 2024

Nov 12, 2024

BUY
$10.81 - $27.22 $233,160 - $587,108
21,569 Added 168.68%
34,356 $371,000
Q2 2024

Aug 07, 2024

BUY
$20.93 - $30.01 $267,631 - $383,737
12,787 New
12,787 $268,000

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $135M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.